StockNews.com Begins Coverage on Fresenius Medical Care (NYSE:FMS)

Research analysts at StockNews.com started coverage on shares of Fresenius Medical Care (NYSE:FMS) in a research note issued on Friday. The brokerage set a “strong-buy” rating on the stock.

Several other brokerages also recently issued reports on FMS. Truist Financial raised their price objective on shares of Fresenius Medical Care from $22.00 to $23.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. Berenberg Bank initiated coverage on shares of Fresenius Medical Care in a research report on Wednesday, November 6th. They issued a “buy” rating and a $25.60 price target on the stock. Finally, Bank of America raised shares of Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd. One analyst has rated the stock with a sell rating, two have assigned a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $24.30.

Fresenius Medical Care Trading Up 1.0 %

Fresenius Medical Care stock opened at $22.38 on Friday. Fresenius Medical Care has a 52 week low of $17.93 and a 52 week high of $24.31. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37. The firm has a market capitalization of $13.13 billion, a PE ratio of 18.50, a PEG ratio of 0.96 and a beta of 0.92. The business’s 50-day simple moving average is $22.24 and its 200-day simple moving average is $20.65.

Institutional Investors Weigh In On Fresenius Medical Care

Institutional investors and hedge funds have recently bought and sold shares of the business. Allworth Financial LP lifted its holdings in shares of Fresenius Medical Care by 53.1% during the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock worth $36,000 after acquiring an additional 581 shares during the period. Wilmington Savings Fund Society FSB bought a new position in Fresenius Medical Care during the third quarter worth about $38,000. GAMMA Investing LLC boosted its holdings in Fresenius Medical Care by 50.4% during the third quarter. GAMMA Investing LLC now owns 4,998 shares of the company’s stock valued at $106,000 after purchasing an additional 1,675 shares in the last quarter. ORG Wealth Partners LLC acquired a new stake in Fresenius Medical Care during the third quarter valued at approximately $112,000. Finally, Venturi Wealth Management LLC raised its holdings in shares of Fresenius Medical Care by 1,045.8% in the 3rd quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company’s stock worth $112,000 after buying an additional 4,800 shares in the last quarter. Institutional investors own 8.37% of the company’s stock.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.